Lipid nanoparticle system demonstrating targeted drug delivery mechanism.
Webinars

Next-generation CE-SDS: Practical Strategies for Today's Biopharma Lab

Gain practical insights into modernizing CE-SDS workflows to improve laboratory productivity, increase throughput, and support growing analytical demands.

Presented byDavid Abraham
Brought to you bySCIEX

By attending this webinar you will:

  • Gain practical insights into modernizing CE-SDS workflows to improve laboratory productivity, increase throughput, and support growing analytical demands.
  • Learn real-world considerations for method transfer and platform adoption.
  • Discover how advanced detection approaches such as native fluorescence detection can enhance sensitivity and streamline AAV characterization workflow.

Event Overview

CE-SDS (capillary electrophoresis-sodium dodecyl sulfate) remains a cornerstone technique for biotherapeutic characterization. Today's laboratories require greater throughput, flexibility, and analytical performance. Join our industry expert as he shares real-world experiences implementing next-generation CE-SDS workflows. Explore lessons learned from transitioning established methods to a multi-capillary platform and discover how native fluorescence detection is enhancing AAV capsid protein analysis with improved sensitivity, streamlined workflows, and label-free detection.

  • Scale CE-SDS throughput with automation and parallel analysis. 
  • Streamline CE-SDS method transfer to next-generation platforms.
  • Enhance AAV method development with label-free native fluorescence detection. 

What you need to know

Date:  19 November, 2026

Start time: 
9 am PST (Los Angeles) / 11 am CST (Chicago) / 12 pm EST (New York) /   5 pm GMT (London/Lisbon)

Who should attend
Scientists, lab managers, and technology decision makers who want to increase CE-SDS throughput, streamline method transfer, and apply new detection technologies to support evolving biopharmaceutical modalities. 

Speaker

  • David Abraham headshot

    Laboratory Automation Engineer II, KBI Biopharma
    David Abraham is a Laboratory Automation Engineer II at KBI Biopharma, where he focuses on advancing analytical and process development through automation, digital tools, and continuous improvement. With a background in analytical chemistry and deep experience supporting biologics and biosimilar development, David brings a practical perspective on applying innovative technologies to streamline workflows and enhance scientific outcomes. He holds a Master's degree in Analytical Chemistry from the University of North Carolina at Chapel Hill.

    View Full Profile

Sponsored by

  • SCIEX BW logo